GNA Biosolutions Overview

  • Founded
  • 2010

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

GNA Biosolutions General Information

Description

Manufacturer of molecular diagnostic devices intended to detect and analyze deoxyribonucleic acid (DNA). The company's device uses a pulse-controlled amplification technology to feature nucleic acid amplification and detection with fast heating and cooling rates, enabling laboratories to diagnose and amplify human pathogens and deoxyribonucleic acid (DNA) in an efficient and simplified way.

Contact Information

Website
www.gna-bio.com
Formerly Known As
Nanostove Project
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Am Klopferspitz 19
  • Martinsried, Planegg
  • 82152 Munich
  • Germany
+49 089 000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GNA Biosolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 05-Feb-2021 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 30-Aug-2019 000.00 000.00 000.00 Completed Generating Revenue
5. Accelerator/Incubator 18-Jun-2019 00.000 Completed Generating Revenue
4. Later Stage VC (Series B) 19-Jun-2015 00.000 00.000 000.00 Completed Startup
3. Early Stage VC (Series A) 20-Dec-2012 Completed Startup
2. Early Stage VC 14-Mar-2011 Completed Startup
1. Spin-Off 01-Jan-2010 Completed Startup
To view GNA Biosolutions’s complete valuation and funding history, request access »

GNA Biosolutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of molecular diagnostic devices intended to detect and analyze deoxyribonucleic acid (DNA). The company's d
Diagnostic Equipment
Munich, Germany
32 As of 2023
000.00
000000&0 000.00

0000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
0000000000 000000000
London, United Kingdom
000 As of 0000
000.00
00000000000 000.00

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000000000 000000000
Frederick, MD
00 As of 0000
0000
0000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GNA Biosolutions Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAe Venture Capital-Backed London, United Kingdom 000 000.00 00000000000 000.00
000000 0000000000 Venture Capital-Backed Frederick, MD 00 0000 0000000000 0000
0000000000 0000000 Corporation Tucson, AZ 000 000.00 0000000000 000.00
00000000 000000000 Formerly VC-backed Menlo Park, CA 0 00.000 00000000000 00.000
00000 Venture Capital-Backed Saint Louis, MO 0 000.00 00000000000 000.00
You’re viewing 5 of 13 competitors. Get the full list »

GNA Biosolutions Patents

  • 36

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

GNA Biosolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102017123919-A1 Method and apparatus for lysing microorganisms Inactive 13-Oct-2017 000000000 0
CA-2967011-C Pcr method for super-amplification Active 07-Nov-2014 0000000000
CA-2967011-A1 Pcr method for super-amplification Active 07-Nov-2014 0000000000
US-10544450-B2 Method for duplicating nucleic acids by means of a polymerase chain reaction Active 07-Nov-2014 0000000000
US-20180237842-A1 Pcr method for super-amplification Active 07-Nov-2014 C12Q1/6844 0
To view GNA Biosolutions’s complete patent history, request access »

GNA Biosolutions Executive Team (6)

Name Title Board Seat Contact Info
Joachim Stehr Ph.D Co-Founder, CSO & Managing Director
Federico Bürsgens Ph.D Co-Founder, Chief Executive Officer & Managing Director
Lars Ullerich Ph.D Co-Founder, CBO & Managing Director
Martin Weber Chief Technology Officer
Anastasia Liapis Ph.D Chief Marketing Officer
You’re viewing 5 of 6 executive team members. Get the full list »

GNA Biosolutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GNA Biosolutions Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayern Kapital Venture Capital Minority 000 0000 000000 0
Bosch Ventures Corporate Venture Capital Minority 000 0000 000000 0
GreyBird Ventures Venture Capital Minority 000 0000 000000 0
Inovis Corporation Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial